XML 120 R103.htm IDEA: XBRL DOCUMENT v3.20.4
Compensation and Benefit Plans (Stock Option Activity) (Details) - Stock options
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2020
USD ($)
$ / shares
shares
Stock Options  
Beginning balance (in shares) | shares 9,278,677
Grants (in shares) | shares 1,993,954
Forfeited or expired (in shares) | shares (203,340)
Exercised (in shares) | shares (359,908)
Ending balance (in shares) | shares 10,709,383
Vested and expected to vest (in shares) | shares 10,391,796
Exercisable (in shares) | shares 6,489,876
Exercise Price  
Beginning balance, weighted average exercise price (in dollars per share) | $ / shares $ 62.27
Granted, weighted average exercise price (in dollars per share) | $ / shares 68.60
Forfeited or expired, weighted average exercise price (in dollars per share) | $ / shares 65.75
Exercised, weighted average exercise price (in dollars per share) | $ / shares 48.59
Ending balance, weighted average exercise price (in dollars per share) | $ / shares 63.85
Vested and expected to vest, weighted average exercise price (in dollars per share) | $ / shares 63.60
Exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 62.08
Remaining Contractual Term (Years)  
Outstanding (term) 6 years 10 days
Vested and expected to vest (term) 6 years 2 months 1 day
Exercisable (term) 4 years 9 months 29 days
Aggregate Intrinsic Value (in millions)  
Vested and expected to vest at December 31, 2020 | $ $ 30
Exercisable at December 31, 2020 | $ 27
Exercise of option, tax benefit | $ $ 2
SCE  
Stock Options  
Beginning balance (in shares) | shares 4,934,702
Grants (in shares) | shares 1,053,923
Forfeited or expired (in shares) | shares (189,691)
Exercised (in shares) | shares (302,911)
Transfers, net (in shares) | shares (5,535)
Ending balance (in shares) | shares 5,490,488
Vested and expected to vest (in shares) | shares 5,325,052
Exercisable (in shares) | shares 3,361,238
Exercise Price  
Beginning balance, weighted average exercise price (in dollars per share) | $ / shares $ 61.01
Granted, weighted average exercise price (in dollars per share) | $ / shares 68.27
Forfeited or expired, weighted average exercise price (in dollars per share) | $ / shares 65.75
Exercised, weighted average exercise price (in dollars per share) | $ / shares 49.49
Transfers, net, weighted average exercise price (in dollars per share) | $ / shares 63.36
Ending balance, weighted average exercise price (in dollars per share) | $ / shares 62.85
Vested and expected to vest, weighted average exercise price (in dollars per share) | $ / shares 62.50
Exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 60.41
Remaining Contractual Term (Years)  
Outstanding (term) 5 years 10 months 9 days
Vested and expected to vest (term) 5 years 11 months 23 days
Exercisable (term) 4 years 6 months 21 days
Aggregate Intrinsic Value (in millions)  
Vested and expected to vest at December 31, 2020 | $ $ 20
Exercisable at December 31, 2020 | $ 19
Exercise of option, tax benefit | $ $ 2